Arrowhead Pharmaceuticals Secures Positive CHMP Opinion for REDEMPLO® (plozasiran) in FCS Treatment
Arrowhead Pharmaceuticals Secures Positive CHMP Recommendation for REDEMPLO® (plozasiran) to Treat Elevated Triglycerides in Adults with Familial Chylomicronemia Syndrome in Europe Arrowhead Pharmaceuticals has taken a significant step forward in…
Samsung Epis Holdings Issues Corrected and Updated First Quarter 2026 Financial Results
Correction and Replacement: Samsung Epis Holdings Announces First Quarter 2026 Financial Results Samsung Epis Holdings has released its financial results for the first quarter of fiscal year 2026, presenting a…
Reflow Medical Launches Next-Generation Cora Flex® and Cora Force® Torqueable Microcatheters in the U.S.
Reflow Medical Unveils U.S. Launch of Next-Generation Cora Flex® and Cora Force® Torqueable Microcatheters Reflow Medical, Inc. has announced the U.S. commercial launch of its next-generation Cora Flex® and Cora…
Study Links Muscle Composition to Elevated Chronic Kidney Disease Risk and Higher Mortality
New AMRA Study Links Muscle Composition to Elevated Risk of Chronic Kidney Disease and Increased Mortality AMRA Medical has released new research shedding light on an important and previously underappreciated…
EndoTool IV Data at AACE Highlights Near Elimination of Severe Hypoglycemia Across 19 Hospitals
New EndoTool IV Data Presented at AACE Demonstrates Near Elimination of Severe Hypoglycemia Across 19 Hospitals Glooko, Inc., a globally integrated digital health company dedicated to improving diabetes management and…
Anaxiom Reports Early First-in-Human Results for Novel Minimally Invasive Obesity Device, Moves Toward U.S. Feasibility Study
Anaxiom Reports Initial First-in-Human Clinical Results for Novel Minimally Invasive Obesity Device, Progresses Toward U.S. Early Feasibility Study Anaxiom Corporation, a clinical-stage innovator focused on developing minimally invasive solutions for…
HealthPartners Outlines Progress, Strategic Priorities, and Next Steps to Simplify and Reduce Health Care Costs
HealthPartners Highlights Ongoing Progress, Key Priorities, and Future Actions to Advance Simpler, More Affordable Health Care Amid a persistent rise in both medical and pharmacy costs, HealthPartners is stepping up…
GE HealthCare Doses First Patient in Phase 2/3 LUMINA Trial for Manganese MRI Contrast Agent
GE HealthCare Doses First Patient in Phase 2/3 LUMINA Trial of Manganese-Based MRI Contrast Agent Under FDA Fast Track Status, Advancing Imaging Innovation Pipeline GE HealthCare has announced a major…
Ironwood Pharmaceuticals to Present HCP Insights on TPN Burden in Short Bowel Syndrome at Digestive Disease Week® 2026
Ironwood Pharmaceuticals to Present Real-World Clinician Insights on Total Parenteral Nutrition Burden in Short Bowel Syndrome at Digestive Disease Week® 2026 Ironwood Pharmaceuticals, Inc. has announced that it will present…
Bausch + Lomb Publishes Review on B Vitamins and AMD Risk Reduction
Bausch + Lomb Publishes Review on B Vitamins and Their Role in Reducing Risk and Progression of Age-Related Macular Degeneration Bausch + Lomb Corporation has announced the publication of a…
BNB Plus Corp. Finalizes Landmark $1.2M LineaDNA™ Order
BNB Plus Corp. Finalizes Landmark $1.2 Million LineaDNA™ Order BNB Plus Corp. has announced a significant operational milestone through its biopharmaceutical subsidiary, LineaRx, Inc., which has successfully completed the largest…
CatalYm Moves Visugromab into Phase 2/3 Trials for Cancer Cachexia, Doses First Patient
CatalYm Initiates Phase 2/3 Trial of Visugromab in Cancer Cachexia with First Patient Dosed CatalYm has announced an important milestone in its clinical development pipeline with the dosing of the…